Tag: BridgeBio Pharma

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to BridgeBio Pharma

Millennium Management LLC Reduces Stock Position in BridgeBio Pharma (NASDAQ:BBIO)

Added to Collection on: 2020-01-07 14:11:15

Tags for this article:

Financial markets
Finance
Financial economics
Equity securities
Stock market
Financial regulation
Short
Stock
Share
BridgeBio Pharma
FTSE 100 Index
NASDAQ COMPOSITE INDEX

Click the tags to see associated articles and topics

View Article Details
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) Chairman Sells 17150 Shares of Stock

Added to Collection on: 2020-01-07 19:15:00

Tags for this article:

Financial regulation
Short
Economy
Finance
Financial economics
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
BridgeBio Pharma (NASDAQ:BBIO) Chairman Sells 82850 Shares

Added to Collection on: 2020-01-14 23:45:00

Tags for this article:

Financial regulation
Short
Economy
Finance
Financial economics
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
Michael Thomas Henderson Sells 3617 Shares of BridgeBio Pharma (NASDAQ:BBIO) Stock

Added to Collection on: 2020-01-20 02:56:15

Tags for this article:

Equity securities
Stock market
Financial economics
Finance
Corporate finance
Stock
Share
Market economics)
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
Maze allies with BridgeBio and Alloy to create 2 biotechs

Added to Collection on: 2020-12-07 13:40:36

Tags for this article:

Companies
Contract research organizations
PAREXEL
Bristol-Myers Squibb
T-maze
Life Sciences
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
BridgeBio Pharma, Inc. and The Lundquist Institute Collaborate to Advance Treatments for ...

Added to Collection on: 2021-04-13 11:26:15

Tags for this article:

Communication
Forward-looking statement
Cancer
Harbor–UCLA Medical Center
Biotechnology
Articles
California
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
BridgeBio Pharma (NASDAQ:BBIO) PT Lowered to $80.00 at The Goldman Sachs Group

Added to Collection on: 2021-05-13 12:11:15

Tags for this article:

Finance
Money
Financial markets
Stock market
Financial regulation
Short
Stock
Financial analyst
Price?earnings ratio
Kite Pharma
Zealand Pharma
BridgeBio Pharma Company
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
Heart drug's trial failure busts bid to best Pfizer, but BridgeBio still bets on coming data

Added to Collection on: 2021-12-27 19:15:07

Tags for this article:

Health sciences
Health
Life Sciences
Orphan drugs
Clinical research
Design of experiments
Drug discovery
Pharmaceutical industry
Familial amyloid polyneuropathy
Transthyretin
Tafamidis
Amyloidosis
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
Gearing Up to Challenge Pfizer in a Rare Disease, BridgeBio Secures Up to $1.25B

Added to Collection on: 2024-01-18 22:54:34

Tags for this article:

Amyloidosis
Neurological disorders
Orphan drugs
Alnylam Pharmaceuticals
Therapeutic gene modulation
RNA
Tafamidis
Familial amyloid polyneuropathy
Acoramidis
Pfizer
RNA interference
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details
BridgeBio strikes drug royalty deal for cash infusion - BioPharma Dive

Added to Collection on: 2024-01-18 16:52:30

Tags for this article:

Therapeutic gene modulation
Alnylam Pharmaceuticals
Leerink Partners
Tafamidis
Royalty payment
Food and Drug Administration
BridgeBio Pharma

Click the tags to see associated articles and topics

View Article Details